Fuzhi Ai

Fuzhi Ai

Auto-generated profile, based on publicly available information

Fuzhi Ai

Sun Yat-sen University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

3 May 2015 in European Spine Journal
Verified
Journal Article
Open access
PDF file
BXBo Xu
Bo Xu
Li RenLi Ren
Li Ren
WTWeifeng Tu
Weifeng Tu
ZWZenghui Wu
Zenghui Wu
FAFuzhi Ai
Fuzhi Ai
XZXingan Zhang
Xingan Zhang
A prospective randomized clinical trial was carried out to observe the analgesic efficacy of ropivacaine for postoperative pain following thoracolumbar spinal surgery. Seventy-one patients with elective posterior thoracolumbar spinal surgery were randomly divided into two groups. Local group received 0.33 % ropivacaine by pump through the wound, and intravenous group received flurbiprofen axetil, pentazocine and palonosetron via intravenous pump. We evaluated the level of pain, the incidence of adverse reactions at 2, 4, 6, 12, 24, 36 and 48 h after operation, and the occurrence of chronic pain 3 months later. There were no significant differences in the pain level between the two groups. However, the incidence of nausea, vomiting and chronic pain was significantly lower in the local group. Our results showed that local infusion of ropivacaine achieved similar analgesic effects to intravenous delivery of analgesic drugs, but significantly reduced incidence of nausea, vomiting and chronic pain.

13 May 2025 in Journal of Advanced Research
Verified
Journal Article
Open access
BTBizhi Tan
Bizhi Tan
XLXiao Liu
Xiao Liu
SCShuai Chen
Shuai Chen
YCYan Chen
Yan Chen
ZHZhongyuan He
Zhongyuan He
FAFuzhi Ai
Fuzhi Ai
Notoginsenoside R1 (NGR1), a bioactive compound, exhibits significant pro-angiogenic potential, making it a promising candidate for treating various diseases. Since angiogenesis and osteogenesis are synergistically coupled processes, NGR1's capacity to stimulate blood vessel formation may critically promote bone regeneration. However, the underlying molecular mechanisms through which NGR1 promotes angiogenesis in bone repair remain to be fully elucidated. To investigate the potential mechanism by which NGR1 promotes angiogenesis and to validate the therapeutic effect of NGR1-loaded biomaterials on bone defect regeneration. Human umbilical vein endothelial cells (HUVECs) were cultured in complete medium containing the screened concentration of NGR1 to investigate its pro-angiogenic phenotype and potential mechanism in vitro. Subsequently, an injectable nano-hydroxyapatite-incorporated GelMA hydrogel was synthesized as an active drug-delivery delivery system for NGR1. The therapeutic effect of this fabricated NGR1-loaded biomaterial on bone defect regeneration was further evaluated in a rat cranial bone defect model. The key molecules in relevant signaling pathways was analyzed by immunohistochemistry. In vitro experiments demonstrated that NGR1 exhibits good biocompatibility and angiogenic capacity, as it promoted cell proliferation, enhanced cell migration, upregulated the angiogenic-related gene expression, and increased the protein expression of VEGF and VEGFR-2. Furthermore, the implantation of the injectable nano-hydroxyapatite-incorporated GelMA hydrogel loaded with NGR1 significantly enhanced bone defect regeneration in a rat cranial bone defect model compared to hydrogel-only group. Additionally, NGR1 supplementation markedly upregulated CD31 expression during bone formation, suggesting its role in coupling of angiogenesis and osteogenesis. Mechanistically, both in vivo and in vitro experiments indicated that NGR1 likely promote angiogenesis via activating Notch1/Akt singling pathway during bone regeneration. These findings indicate that NGR1 promotes angiogenesis through Notch1/Akt signaling activation during bone regeneration, which might offer potential therapeutic targets for bone-related diseases. Moreover, the application of NGR1-loaded biomaterials could represent a promising strategy to enhance bone regeneration.

6 April 2023 in Spine
Verified
Journal Article
Closed access
JXJing Xu
Jing Xu
SMShaodong Mm Mo
Shaodong Mm Mo
XMXiangyang Ma
Xiangyang Ma
JWJianhua Wang
Jianhua Wang
KZKai Zhang
Kai Zhang
FAFuzhi Ai
Fuzhi Ai
Study Design.: Retrospective cohort study. Objective.: To verify the clinical efficacy of a novel transoral stepwise release technique (TSRT) for the treatment of irreducible atlantoaxial dislocations (IAAD). Summary of Background Data.: Anterior release for IAAD remains challenging, with a 3.2 times higher complication rate than posterior release. However, there are some patients who cannot achieve successful reduction from a posterior approach and require the higher-risk anterior release. Our work presents a novel anterior release technique that aims to minimize iatrogenic injury and associated complications from an anterior release. Materials and Methods.: IAAD cases who were treated with TSRT were retrospectively studied. Primary outcomes included fusion rate, complications, and neurological function over the course of a minimum 1-year follow-up. Radiographic differences between preoperative and postoperative imaging were also considered. A preoperative prediction model for the actual release grade was developed using multivariate logistic regression based on demographic factors and the craniovertebral abnormalities identified on preoperative images, evaluating the need for higher-grade TSRT release. Results.: We included 201 IAAD cases, with 42% (84/201) demonstrating degeneration of the atlantoaxial joint or anterior–hook-like dens. The reduction was achieved in all cases, with 80% (160/201) of cases only requiring relatively low-grade or grade I types TSRT release. Degeneration of the atlantoaxial joint was significantly associated with the need for higher-grade TSRT release (odds ratio:16.68, CI: 2.91–94.54, P = 0.002). The overall complication rate was 4.5% (9/201). Over the course of follow-up, the fusion rate reached 98.5%, and the American Spinal Injury Association and Japanese Orthopedic Association scores were significantly improved to 97.28 and 16.25 (P < 0.01 and P < 0.01), respectively. Conclusion.: This study demonstrated that our novel TSRT anterior release technique demonstrated complication rates similar to those published in the literature for posterior release. TSRT can be used as an alternative to posterior release techniques for refractory cases or when a posterior approach is not considered viable.

18 December 2025 in Research Square
Verified
Preprint
Open access
PDF file
XWXueting Wang
Xueting Wang
ZCZiqi Cai
Ziqi Cai
YLYamin Lu
Yamin Lu
FAFuzhi Ai
Fuzhi Ai
WYWeiguang Yao
Weiguang Yao
Background Chronic respiratory disease (CRD) is a global priority in preventing and controlling non-communicable diseases (NCDs). Its disease burden and health inequalities significantly undermine population health outcomes. This study examines inequalities in health service utilization and CHE incidence among middle-aged/elderly CRD patients in China, identifying key drivers. Methods Using 2013–2020 China Health and Retirement Longitudinal Study(CHARLS) data, this study analyzed outpatient, inpatient, and physical examination utilization rates and CHE incidence in CRD patients ≥ 45 years. The degree of inequality and its main contributing factors were measured using indirect standardization, the concentration index (CI), and decomposition analysis. Results All service utilization rates increased from 2013 to 2020. CIs declined but remained positive in 2020 (outpatient: 0.020; inpatient: 0.059; physical examination: 0.017). Health behaviors reduced outpatient inequality, while age 65 and above drove inpatient and physical examination disparities. CHE incidence rose from 10.40% (2013) to 11.67% (2020), with CIs worsening (-0.027 to -0.048). Urban residence (13.55%) and non-agricultural hukou (8.82%) were the main drivers of inequality at CHE. Conclusions Although equity improved in outpatient, inpatient, and physical examination service utilization during the study period, persistent pro-rich inequalities remain. CHE incidence demonstrated widening pro-poor disparities. Policy priorities should target unmet needs and economic burdens among socioeconomically disadvantaged groups through strengthened health education, behavioral interventions, health insurance reforms, and enhancements to the primary care system.